What are the imported liver cancer drugs

Liver cancer is a malignant tumor of the liver. It is a common and frequently-occurring disease among surgical diseases. Malignant tumors of the liver can be divided into two categories: primary and secondary. In clinical treatment, most Western medicine treatments use palliative treatment, that is, symptomatic treatment of symptoms, relief of the patient's condition, and improvement of the patient's quality of life. If the plan is ineffective, pain relief treatment is the main treatment. Traditional Chinese medicine focuses on protecting the liver and improving overall immunity, that is, strengthening the body. This plays a role in prolonging the life cycle.

The emergence of the molecular targeted drug Nexavar (sorafenib) for the treatment of advanced liver cancer. Nexavar has been shown to significantly prolong the overall survival of patients with advanced hepatocellular carcinoma ( HCC) and has been approved for systemic treatment of advanced liver cancer. Its emergence has ushered in a new era of targeted treatment for advanced liver cancer and brought new hope to systemic treatment of advanced liver cancer.

The treatment of advanced liver cancer is very difficult, and the research results of Nexavar (sorafenib) have undoubtedly become a new standard for the treatment of advanced liver cancer. The effectiveness of Nexavar has been confirmed by many patients with advanced liver cancer.

Large-scale studies have confirmed that the survival benefit after treatment with Sorafenib is closely related to the disease stage and liver function status of liver cancer patients. That is, the earlier the stage and the better the liver function status, the greater the benefit after treatment with Sorafenib.

In summary, as an imported anti-liver cancer drug, Nexavar has a very good effect. Even in the late stage of liver cancer, the earlier the drug is used, the better the effect.